Related Experiment Video

Updated: Sep 26, 2026

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

Genetic epidemiology of Trypanosoma cruzi infection and Chagas' disease

Sarah Williams-Blangero1, John L VandeBerg, John Blangero

  • 1Department of Genetics, Southwest Foundation for Biomedical Research, 7620 NW Loop 410, San Antonio, TX 78227, USA. sarah@darwin.sfbr.org

Frontiers in Bioscience : a Journal and Virtual Library
|April 18, 2003
PubMed

Insights

Genetic factors influence susceptibility and disease severity in Chagas' disease, a major cause of heart disease in Latin America. Understanding these genetic links is crucial for developing new treatments for this widespread zoonotic illness.

Area of Science:

  • Genetics
  • Infectious Diseases
  • Cardiology

Background:

  • Chagas' disease is a significant cause of heart disease in Latin America, impacting millions.
  • Eradication is unlikely due to numerous hosts, necessitating alternative control strategies.
  • Individual variation in susceptibility and disease outcome suggests a role for genetic factors.

Purpose of the Study:

  • To review evidence for genetic control of Trypanosoma cruzi infection susceptibility.
  • To examine genetic influences on Chagas' disease severity.
  • To highlight the potential of genetic studies for drug development.

Main Methods:

  • Review of existing human and animal model research.
  • Analysis of evidence for genetic factors in infection and disease outcome.
  • Discussion of genome scans in human pedigrees.

Main Results:

  • Evidence supports a significant role for genetic factors in Chagas' disease susceptibility.
  • Genetic variations influence the severity of disease outcomes.
  • Genetic studies offer insights into disease determinants.

Conclusions:

  • Genetic factors are key determinants of Chagas' disease susceptibility and severity.
  • Further genetic research, including genome scans, can identify new drug targets.
  • Understanding genetic influences is vital for future therapeutic strategies.

More Related Videos

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model09:23

Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model

Published on: July 29, 2012

Related Concept Videos

American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...